chief scientific officer novo nordisk

News

Novo Nordisk appoints Mike Doustdar as new CEO

Novo Nordisk appoints Mike Doustdar as new CEO; Chief Scientific Officer to retire

Novo Nordisk (NYSE:NVO) announced on Tuesday that Maziar Mike Doustdar will become its new president and chief executive officer, effective August 7, 2025. Doustdar, currently the executive vice president of International Operations,

Yahoo Finance · 2d

Novo Nordisk names Mike Doustdar as new CEO, Chief Scientific Officer retires

Novo Nordisk (NYSE:NVO) has appointed Maziar Mike Doustdar as its new president and chief executive officer, effective August 7, 2025, the company announced on Tuesday.

Fierce Pharma · 2d

Novo Nordisk names new CEO as the obesity drugmaker cuts sales, profit outlook

Novo Nordisk has named Maziar Mike Doustdar, currently the company’s EVP of international operations, as the new CEO. Doustdar will succeed Lars Fruergaard Jørgensen, whose surprise abdication was announced in May.

Novo Nordisk Foundation and the Evolution of Quantum Computing: Tech Disruptors

Professor Lene Oddershede Chief Scientific Officer, Planetary Science & Technology at the Novo Nordisk Foundation talks about the applications of quantum computing at the tech disruptors podcast. She ...

Pharmaceutical Technology on MSN1d

Novo Nordisk shares plummet as 2025 guidance is cut, overshadowing new CEO

CEO-to-be Maziar Mike Doustdar will need to stem the company’s tumbling share price as market pressures intensify.

Medical Marketing & Media21h

The Escalator: Novo Nordisk, The FDA, Bristol Myers Squibb and more

Novo Nordisk promoted Maziar Mike Doustdar to president and CEO, effective August 7. The Food and Drug Administration tapped newly appointed George Tidmarsh as acting Center for Biologics Evaluation ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results